While these can reduce inflammation, they often bring difficult side effects: Weight gain, bloating, and bone loss Increased infection risk Fatigue and mood changes High long-term costs Because these drugs suppress the immune system instead of balancing it, flare-ups frequently return once treatment stops
Future research should continue to explore the impact of commensal translocation on AD development/progression to facilitate the development of therapeutics that perhaps target the microbiota to indirectly inhibit chronic inflammation in the gut and beyond
Russo et al., AIDS, 2024)
Research Citations & Literature Multi-Receptor Agonism : Triple-Hormone-Receptor Agonist Reta for Obesity Metabolic Signaling : Reta, a GIP, GLP-1 and glucagon receptor agonist Comparative Analysis : The development of multi-receptor agonists for metabolic research Looking for a different MG
Others inhibit osteoclast formation